Virtual primary care platform Hello Alpha has teamed up with Phenomix Sciences, a precision medicine biotechnology company, the companies announced Tuesday. The partnership will give Hello Alpha’s patients access to Phenomix Sciences’ genetic obesity…
Continue Reading
Melissa Easy, VP & General Manager of Clinical Technologies, IQVIA
The clinical trial landscape has greatly benefited from technological innovations over the past few decades. Innovation has expanded remote monitoring capabilities, patient recruitment tactics and…
Continue Reading
The established environmentalism mantra of “reduce, re-use, recycle” opened the door for medical device manufacturers to roll out recycling programs under the guise of sustainability efforts. But, in practice, these programs aren’t benefiting anyone…
Continue Reading
West Northamptonshire Council has signed a five-year contract with social care specialist System C to implement its cloud-based case management app for adult social care in the region.
The Liquidlogic system is due to go…
In today’s fast-paced healthcare environment, providers face numerous challenges that can detract from their ability to deliver top-notch patient care. However, technology is stepping up to the plate, offering solutions to streamline processes and…
Continue Reading
Healthcare cyberattacks remain a constant threat for hospitals, endangering their ability to provide efficient care and putting them at risk for serious financial losses and data privacy violations. This type of cybercriminal activity doesn’t…
Continue Reading
Highmark is collaborating with Laguna Health, a conversational artificial intelligence company, to ease the administrative burden on care managers, the companies announced on Wednesday.
Pittsburgh, Pennsylvania-based Highmark is an independent licensee of the Blue Cross…
Continue Reading
In 2022, 12.8% of U.S. households were food insecure. Foodsmart, a telenutrition and food benefits management platform, aims to address this after announcing last week that the Rise Fund has signed a definitive agreement…
Continue Reading
Diabetes remains one of the nation’s most prevalent and dangerous chronic conditions, affecting nearly 15% of U.S. adults and causing more than 100,000 deaths each year. As a response, the landscape of medical devices…
Continue Reading
What You Should Know:
– Eli Lilly’s Kisunla™ (donanemab-azbt) has been approved by the FDA as a treatment for adults in the early stages of Alzheimer’s disease (AD), including those with mild cognitive impairment (MCI)…
Continue Reading
